NuGen Medical Devices Inc. logo

NuGen Medical Devices Inc. (NGMD)

Market Closed
7 Aug, 13:31
TSX-V TSX-V
CA$
0. 01
0
0%
CA$
- Market Cap
- P/E Ratio
- Div Yield
260,000 Volume
- Eps
CA$ 0.01
Previous Close
Add Transaction
Day Range
0.01 0.01
Year Range
0.01 0.06
Want to track NGMD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NGMD closed Friday higher at CA$0.01, an increase of 0% from Thursday's close, completing a monthly decrease of -25% or -CA$0.01. Over the past 12 months, NGMD stock lost -50%.
NGMD is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

NGMD Chart

NuGen Medical Devices Inc. (NGMD) FAQ

What is the stock price today?

The current price is CA$0.01.

On which exchange is it traded?

NuGen Medical Devices Inc. is listed on TSX-V.

What is its stock symbol?

The ticker symbol is NGMD.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has NuGen Medical Devices Inc. ever had a stock split?

No, there has never been a stock split.

NuGen Medical Devices Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Lin Liang CEO
TSX-V Exchange
CA67054F1009 ISIN
CA Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

NuGen Medical Devices Inc. is a specialty medical device company with a sharp focus on the development and commercialization of innovative drug delivery technologies. Positioned as a leader in the needle-free injection technology field, the company caters to a wide range of medical needs, from chronic diseases to vaccinations. NuGen's mission is to enhance the administration of subcutaneous medications, making it safer, quicker, and more comfortable for patients across various medical fields. Originally known as BuzBuz Capital Corp., NuGen has reinvented itself to address the significant need for needle-free drug delivery systems. Headquartered in Toronto, Canada, NuGen is committed to improving patient care and treatment outcomes on a global scale.

Products and Services

NuGen Medical Devices Inc. offers a comprehensive range of needle-free injection devices and systems designed to transform patient experience and improve medication administration efficiency across multiple therapeutic areas:

  • Anaphylaxis: Specialized devices for rapid and needle-free administration of life-saving medications for severe allergic reactions, enhancing accessibility and user-friendliness in emergency situations.
  • Diabetes: Innovations in insulin delivery for diabetes patients, allowing for painless and precise dosing, which is crucial for effective diabetes management and patient compliance.
  • Severe Migraine: Delivery solutions tailored for individuals suffering from severe migraine, providing fast-acting medication administration without the distress of traditional needle-based injections.
  • Erectile Dysfunction: Discreet and needle-free drug delivery systems designed for the treatment of erectile dysfunction, offering patients a less invasive and more acceptable treatment option.
  • Chronic Anemia & Neutropenia: Advanced devices that facilitate the convenient administration of medication for diseases like chronic anemia and neutropenia, improving patient compliance and treatment efficacy.
  • Autoimmune Rheumatoid Arthritis: Needle-free systems that deliver drugs precisely and with minimal discomfort, significantly improving the quality of life for patients with rheumatoid arthritis.
  • Growth and Fertility Hormone: Cutting-edge devices for the administration of hormones related to growth and fertility treatment, enhancing ease of use and reducing the psychological barrier associated with injections.
  • Psoriasis: Specialized injection devices for the treatment of psoriasis, aimed at offering a more comfortable and less intimidating medication delivery method for patients dealing with this chronic skin condition.
  • DNA and Conventional/Pediatric Vaccines: Breakthrough needle-free technology for the delivery of DNA-based and conventional vaccines, including those for pediatric use, setting new standards in public health by improving vaccination rates through better patient compliance and reduced vaccine hesitancy.

Contact Information

Address: 18 King Street East
Phone: 833 285 2666